… Molecular imaging of dopaminergic dysfunction in Parkinson’s disease. PET and SPECT
imaging in a PD patient show reduction of VMAT2 activity, DAT availability, and DDC activity …

… imaging as a biomarker for early disease detection and for the study of disease progression.
… Although much of the interest in imaging approaches in Parkinson's disease has focused on …

… frequently used Parkinson’s disease (PD) biomarkers are the brain imaging measures of …
imaging (MRI) biomarkers for PD in the past decade. Although conventional structural imaging …

… -up of Parkinson’s disease. This includes not only the exclusion of alternative diagnoses for
Parkinson’s disease such as symptomatic parkinsonism and atypical parkinsonism, but also …

… role of structural and functional imaging for understanding … known to be associated with
parkinsonism (alpha synuclein, … with abnormal imaging developed clinical parkinsonism over …

… imaging techniques as surrogate biomarkers of disease … validate imaging outcomes as
biomarkers of disease progression. … imaging still offers an objective method of assessing disease …

… Functional imaging provides four potential approaches toward determining the roles of …
of motor actions and other behaviors in health and Parkinson’s disease (PD): 1) Loss of DA …

… Parkinson’s disease fulfilled the UK Parkinson’s Disease Brain Bank criteria for the diagnosis
of idiopathic Parkinson’s disease… or psychiatric disease other than Parkinson’s disease. All …

… Parkinson's disease (PD) is a neurodegenerative disorder … Molecular imaging methods such
as magnetic resonance imaging … We provide an overview of the imaging targets, discuss the …

… Structural abnormalities in Parkinson’s disease, multiple system atrophy (MSA) and … related
to Parkinson’s disease and other parkinsonian disorders are visualized using MR imaging in …